218 related articles for article (PubMed ID: 22155828)
61. Novel inhibitor of Plasmodium histone deacetylase that cures P. berghei-infected mice.
Agbor-Enoh S; Seudieu C; Davidson E; Dritschilo A; Jung M
Antimicrob Agents Chemother; 2009 May; 53(5):1727-34. PubMed ID: 19223622
[TBL] [Abstract][Full Text] [Related]
62. Trisubstituted Pyrimidines as Efficacious and Fast-Acting Antimalarials.
Norcross NR; Baragaña B; Wilson C; Hallyburton I; Osuna-Cabello M; Norval S; Riley J; Stojanovski L; Simeons FR; Porzelle A; Grimaldi R; Wittlin S; Duffy S; Avery VM; Meister S; Sanz L; Jiménez-Díaz B; Angulo-Barturen I; Ferrer S; Martínez MS; Gamo FJ; Frearson JA; Gray DW; Fairlamb AH; Winzeler EA; Waterson D; Campbell SF; Willis P; Read KD; Gilbert IH
J Med Chem; 2016 Jul; 59(13):6101-20. PubMed ID: 27314305
[TBL] [Abstract][Full Text] [Related]
63. Oral artesunate prevents Plasmodium berghei Anka infection in mice.
Gumede B; Folb P; Ryffel B
Parasitol Int; 2003 Mar; 52(1):53-9. PubMed ID: 12543147
[TBL] [Abstract][Full Text] [Related]
64. Macrolides rapidly inhibit red blood cell invasion by the human malaria parasite, Plasmodium falciparum.
Wilson DW; Goodman CD; Sleebs BE; Weiss GE; de Jong NW; Angrisano F; Langer C; Baum J; Crabb BS; Gilson PR; McFadden GI; Beeson JG
BMC Biol; 2015 Jul; 13():52. PubMed ID: 26187647
[TBL] [Abstract][Full Text] [Related]
65. Defibrotide: a Swiss Army knife intervention in the battle against cerebral malaria.
Moore JM; Avery JW
Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):541-4. PubMed ID: 22345588
[No Abstract] [Full Text] [Related]
66. Simvastatin treatment shows no effect on the incidence of cerebral malaria or parasitemia during experimental malaria.
Kobbe R; Schreiber N; May J; Jacobs T
Antimicrob Agents Chemother; 2008 Apr; 52(4):1583-4. PubMed ID: 18268089
[No Abstract] [Full Text] [Related]
67. Novel potent metallocenes against liver stage malaria.
Matos J; da Cruz FP; Cabrita É; Gut J; Nogueira F; do Rosário VE; Moreira R; Rosenthal PJ; Prudêncio M; Gomes P
Antimicrob Agents Chemother; 2012 Mar; 56(3):1564-70. PubMed ID: 22155838
[TBL] [Abstract][Full Text] [Related]
68. Characterising the effect of antimalarial drugs on the maturation and clearance of murine blood-stage Plasmodium parasites in vivo.
Khoury DS; Cromer D; Elliott T; Soon MSF; Thomas BS; James KR; Best SE; Aogo RA; Engel JA; Gartlan KH; Akter J; Sebina I; Haque A; Davenport MP
Int J Parasitol; 2017 Dec; 47(14):913-922. PubMed ID: 28864033
[TBL] [Abstract][Full Text] [Related]
69. Protection from experimental cerebral malaria with a single dose of radiation-attenuated, blood-stage Plasmodium berghei parasites.
Gerald NJ; Majam V; Mahajan B; Kozakai Y; Kumar S
PLoS One; 2011; 6(9):e24398. PubMed ID: 21935405
[TBL] [Abstract][Full Text] [Related]
70. Terminalia albida treatment improves survival in experimental cerebral malaria through reactive oxygen species scavenging and anti-inflammatory properties.
Camara A; Haddad M; Reybier K; Traoré MS; Baldé MA; Royo J; Baldé AO; Batigne P; Haidara M; Baldé ES; Coste A; Baldé AM; Aubouy A
Malar J; 2019 Dec; 18(1):431. PubMed ID: 31852507
[TBL] [Abstract][Full Text] [Related]
71. Parasite burden and CD36-mediated sequestration are determinants of acute lung injury in an experimental malaria model.
Lovegrove FE; Gharib SA; Peña-Castillo L; Patel SN; Ruzinski JT; Hughes TR; Liles WC; Kain KC
PLoS Pathog; 2008 May; 4(5):e1000068. PubMed ID: 18483551
[TBL] [Abstract][Full Text] [Related]
72. Targeting the IL33-NLRP3 axis improves therapy for experimental cerebral malaria.
Strangward P; Haley MJ; Albornoz MG; Barrington J; Shaw T; Dookie R; Zeef L; Baker SM; Winter E; Tzeng TC; Golenbock DT; Cruickshank SM; Allan SM; Craig A; Liew FY; Brough D; Couper KN
Proc Natl Acad Sci U S A; 2018 Jul; 115(28):7404-7409. PubMed ID: 29954866
[TBL] [Abstract][Full Text] [Related]
73. Synthesis of chlorovinyl sulfones as structural analogs of chalcones and their antiplasmodial activities.
Dominguez JN; Leon C; Rodrigues J; Gamboa de Dominguez N; Gut J; Rosenthal PJ
Eur J Med Chem; 2009 Apr; 44(4):1457-62. PubMed ID: 19036479
[TBL] [Abstract][Full Text] [Related]
74. Antiplasmodial efficacy of
Satish PVV; Kumari DS; Sunita K
J Vector Borne Dis; 2017; 54(3):215-225. PubMed ID: 29097636
[TBL] [Abstract][Full Text] [Related]
75. New quinoline derivatives demonstrate a promising antimalarial activity against Plasmodium falciparum in vitro and Plasmodium berghei in vivo.
Soares RR; da Silva JM; Carlos BC; da Fonseca CC; de Souza LS; Lopes FV; de Paula Dias RM; Moreira PO; Abramo C; Viana GH; de Pila Varotti F; da Silva AD; Scopel KK
Bioorg Med Chem Lett; 2015 Jun; 25(11):2308-13. PubMed ID: 25920564
[TBL] [Abstract][Full Text] [Related]
76. Fast-Acting Small Molecules Targeting Malarial Aspartyl Proteases, Plasmepsins, Inhibit Malaria Infection at Multiple Life Stages.
Singh S; Rajendran V; He J; Singh AK; Achieng AO; Vandana ; Pant A; Nasamu AS; Pandit M; Singh J; Quadiri A; Gupta N; Poonam ; Ghosh PC; Singh BK; Narayanan L; Kempaiah P; Chandra R; Dunn BM; Pandey KC; Goldberg DE; Singh AP; Rathi B
ACS Infect Dis; 2019 Feb; 5(2):184-198. PubMed ID: 30554511
[TBL] [Abstract][Full Text] [Related]
77. Oxidative stress and genes regulation of cerebral malaria upon Zizyphus spina-christi treatment in a murine model.
Mubaraki MA; Hafiz TA; Al-Quraishy S; Dkhil MA
Microb Pathog; 2017 Jun; 107():69-74. PubMed ID: 28336326
[TBL] [Abstract][Full Text] [Related]
78. In vitro and in vivo anti-malarial activity of novel harmine-analog heat shock protein 90 inhibitors: a possible partner for artemisinin.
Bayih AG; Folefoc A; Mohon AN; Eagon S; Anderson M; Pillai DR
Malar J; 2016 Dec; 15(1):579. PubMed ID: 27903279
[TBL] [Abstract][Full Text] [Related]
79. Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy Modeling.
Le Bihan A; de Kanter R; Angulo-Barturen I; Binkert C; Boss C; Brun R; Brunner R; Buchmann S; Burrows J; Dechering KJ; Delves M; Ewerling S; Ferrer S; Fischli C; Gamo-Benito FJ; Gnädig NF; Heidmann B; Jiménez-Díaz MB; Leroy D; Martínez MS; Meyer S; Moehrle JJ; Ng CL; Noviyanti R; Ruecker A; Sanz LM; Sauerwein RW; Scheurer C; Schleiferboeck S; Sinden R; Snyder C; Straimer J; Wirjanata G; Marfurt J; Price RN; Weller T; Fischli W; Fidock DA; Clozel M; Wittlin S
PLoS Med; 2016 Oct; 13(10):e1002138. PubMed ID: 27701420
[TBL] [Abstract][Full Text] [Related]
80. Antimalarial activity of novel arylene bis(methylketone) compounds.
Berger BJ; Paciorkowski A; Suskin M; Dai WW; Cerami A; Ulrich P
J Infect Dis; 1996 Sep; 174(3):659-62. PubMed ID: 8769633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
